One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 3months
-
http://medilib.ir
- Duration of Time : 93 Day
Price : 100$- Special Price : 50$
One image is not enough: AI fuses vision to predict remission Purchased
doi : 10.1093/ecco-jcc/jjaf139
Volume 19, Issue 10, October 2025
Submucosal hyper-echogenicity on intestinal ultrasound is associated with fat deposition and predicts treatment non-response in patients with ulcerative colitis Open Access
doi : 10.1093/ecco-jcc/jjaf158
Comprehensive proteomic profile in newly diagnosed patients with inflammatory bowel disease: identification of potential biomarkers Purchased
doi : 10.1093/ecco-jcc/jjaf177
Spatial transcriptomics reveals unique inflammatory signatures across all anatomic locations in postoperative Crohn’s disease Open Access
doi : 10.1093/ecco-jcc/jjaf180
Switching to subcutaneous administration may offer more profound remission compared to intensified intravenous therapy in patients with inflammatory bowel disease and partial response following induction with intravenous vedolizumab: the PRIVEDO study Purchased
doi : 10.1093/ecco-jcc/jjaf175
Mucosal kinase activity and inflammatory profiles in inflammatory bowel disease, and in relation to tofacitinib response Open Access
doi : 10.1093/ecco-jcc/jjaf174
Examining the role of fecal microbiota transplantation for inducing remission in resistant ulcerative proctitis and distal ulcerative colitis (ulcerative proctitis-fecal microbiota transplantation) Purchased
doi : 10.1093/ecco-jcc/jjaf169
Clonal hematopoiesis of indeterminate potential and risk of incident Crohn’s disease—a prospective cohort study Purchased
doi : 10.1093/ecco-jcc/jjaf118
Establishing a multiple outcome set for Crohn’s disease in real-world evidence studies: results from a Delphi e-survey Purchased
doi : 10.1093/ecco-jcc/jjaf178
Validation of prediction models for anti-tumor necrosis factor treatment response in pediatric Crohn’s disease: a systematic review and prospective cohort study Purchased
doi : 10.1093/ecco-jcc/jjaf172
Pharmacological management of upper gastrointestinal Crohn’s disease: a systematic review Open Access
doi : 10.1093/ecco-jcc/jjaf187
How long is long enough? Timing of pre-conceptional remission predicts relapse risk during pregnancy in IBD Open Access
doi : 10.1093/ecco-jcc/jjaf176
Disease duration impacts intestinal gene expression profiles in Crohn’s disease but not in ulcerative colitis Purchased
doi : 10.1093/ecco-jcc/jjaf179
Spatial transcriptomics and immunophenotyping uncover chronic inflammation-induced immune adaptations favoring dysplasia development in patients at risk of colitis-associated cancer Open Access
doi : 10.1093/ecco-jcc/jjaf184
Addition of baseline histology and fecal calprotectin does not reduce placebo rates in ulcerative colitis clinical trials: post-hoc analysis of patient-level data Open Access
doi : 10.1093/ecco-jcc/jjaf194
Comparison of early ileocolic resection and medical treatment for Crohn’s disease: a systematic review and meta-analysis Purchased
doi : 10.1093/ecco-jcc/jjaf190
Glucagon-like peptide 1 receptor agonists and the clinical outcomes of inflammatory bowel disease: a systematic review and meta-analysis Open Access
doi : 10.1093/ecco-jcc/jjaf181
Placebo rates in randomized clinical trials of ulcerative colitis: an individual patient data meta-analysis Open Access
doi : 10.1093/ecco-jcc/jjaf191
Trends in utilization of advanced therapies in patients with inflammatory bowel diseases in the USA, 2021-2025 Purchased
doi : 10.1093/ecco-jcc/jjaf186
